Some people who suffer from the COVID-19 virus continue to experience symptoms long after the infection, from weeks to months and sometimes even years. While this typically happens in those who were severely ill or hospitalized, anyone who was infected can experience symptoms of long-COVID.
Long-COVID has many names, including Post-COVID Conditions, long-haul COVID, post-acute COVID-19, long-term effects of COVID, and chronic COVID.
Currently, the research shows evidence that antibodies—proteins produced by the immune system in response to viruses and other invaders—are involved in an attack on the cells which line the brain’s blood vessels, leading to inflammation and damage.
In addition to the direct effects on the brain, the infection can attack our body’s organs such as the lungs, heart and kidneys. Damage to these organs can negatively impact our bodies ability to function.
Long COVID brain fog is often caused by neuroinflammation and disrupted communication between brain regions. Ketamine helps by improving neuroplasticity, essentially helping the brain reconnect and communicate more efficiently again.
Patients consistently report clearer thinking, better memory, and improved focus as their brain function stabilizes and reconnects.
Yes. Long COVID fatigue is linked to the same neurological disruption that causes brain fog – inflammation, stress, and breakdown of normal communication between brain cells. When these pathways aren’t firing correctly, energy, focus, and motivation all drop.
Ketamine increases neuroplasticity and helps restore those connections. Many patients experience improved cognitive energy, better stamina, and a noticeable reduction in the “crash” feeling that comes with Long COVID.
No. The loss of taste and smell can be permanent, but the cognitive dysfunction is repairable.
Ketamine increases neuroplasticity, your brain’s ability to form healthier patterns, helping reduce symptoms of depression, anxiety, chronic pain, PTSD, migraines, and other cognitive disorders.
Some patients notice subtle shifts within hours, while others begin to feel meaningful change gradually throughout the Stabilization Phase and beyond. There’s no standardized timeline, as individual responses naturally differ. Minimally Stimulated Ketamine Infusion Therapy (MSKIT®) opens the door for change, and your ongoing work helps guide how that change takes shape. Through neuroplasticity, MSKIT® opens a window where your brain can more easily build healthier patterns: new thoughts, behaviors, habits, and emotional responses. Actively practicing those healthier choices during this time is what makes the difference. The more you engage with these new patterns, the stronger and more sustainable they become.
Ketamine’s benefits can last weeks to several months, but duration varies from person to person. Results depend on the brain’s baseline health, how well new neural capacity is supported, and whether the patient continues healthy brain-care practices after treatment. Many patients maintain progress with periodic booster sessions as needed.
You’ll be in a private, calm environment with continuous monitoring. You will be given eye shades, a blanket if you’d like. You’ll dress comfy. Most people describe the feeling as light, floaty, or similar to nitrous oxide at the dentist. The feeling is temporary and a result of the ketamine.
Stabilization includes six infusions over three weeks. After that, booster sessions are scheduled based on your individual progress and goals.
Most people describe the feeling as light, floaty, or similar to nitrous oxide at the dentist.
You can't mess up Minimally Stimulated Ketamine Infusion Therapy (MSKIT®). The neurological cascade that ketamine initiates in your brain is a biological process that unfolds on its own. You cannot stop it, change it, or do it “wrong.” The vivid thoughts or emotions you may experience during a session are temporary, medication-driven experiences, similar to dreaming, and they do not determine your outcome or hold deeper meaning.
